DRREDDY Dr Reddy's Laboratories Ltd US FDA Inspections Announcement 2023 - Application Accepted for Review Dr. Reddys proposed rituximab biosimilar application accepted for review by USFDA, EMA, and MHRA.Find Corporate Announcements for Press Releases, AGM, Insider Trading & SAST, Results and Corporate Action for Dr Reddy's Laboratories Ltd